Edwards Lifesciences Corp. (EW)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 2 |
Ownership rank: | 356 |
% of all portfolios: | 0.082% |
Hold Price * : | $72.74 |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q1  2024 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 2.07% | 5,201 | 0.09 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,977 | 0.00 | |
Q4  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 43.91% | 2,331 | 0.00 | |
Q3  2023 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 38.51% | 121,376 | 2.01 | |
Q2  2023 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 4.51% | 14,897 | 0.23 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 39.46% | 2,815 | 0.01 | |
≡ | Terry Smith - Fundsmith | Sell 100.00% | 9,979 | 0.00 | |
Q1  2023 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 1.11% | 3,690 | 0.05 | |
≡ | Francois Rochon - Giverny Capital | Reduce 2.63% | 11,198 | 0.06 | |
Q4  2022 | |||||
≡ | Francois Rochon - Giverny Capital | Reduce 0.94% | 4,023 | 0.02 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 74.56% | 10,616 | 0.03 | |
Q3  2022 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 2.66% | 9,062 | 0.14 | |
Q2  2022 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 4.89% | 17,531 | 0.29 | |
Q1  2022 | |||||
≡ | Francois Rochon - Giverny Capital | Reduce 0.17% | 671 | 0.00 | |
Q4  2021 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 25.28% | 119,478 | 2.05 | |
Q3  2021 | |||||
≡ | Francois Rochon - Giverny Capital | Reduce 0.83% | 3,379 | 0.02 | |
≡ | David Rolfe - Wedgewood Partners | Reduce 2.26% | 10,909 | 0.17 | |
Q2  2021 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 5.91% | 30,352 | 0.46 | |
Q1  2021 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 13.63% | 81,068 | 1.04 | |
Q4  2020 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 5.82% | 36,762 | 0.50 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 15,652 | 0.02 | |
Q3  2020 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 5.51% | 36,824 | 0.46 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 48.75% | 14,889 | 0.02 | |
Q2  2020 | |||||
≡ | AKO Capital | Sell 100.00% | 753,568 | 3.00 | |
Q1  2020 | |||||
≡ | Francois Rochon - Giverny Capital | Reduce 7.85% | 10,089 | 0.24 | |
≡ | AKO Capital | Reduce 9.04% | 74,855 | 0.30 | |
≡ | David Rolfe - Wedgewood Partners | Reduce 36.59% | 136,862 | 4.89 | |
≡ | Viking Global Investors | Sell 100.00% | 158,573 | 0.17 | |
Q4  2019 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 21.87% | 104,727 | 2.48 | |
≡ | Viking Global Investors | Reduce 22.32% | 45,575 | 0.05 | |
Q3  2019 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 7.98% | 41,504 | 0.81 | |
Q2  2019 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 21.27% | 140,526 | 2.20 | |
Q1  2019 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 19.52% | 160,313 | 2.24 | |
Q4  2018 | |||||
≡ | Francois Rochon - Giverny Capital | Reduce 32.38% | 58,512 | 1.18 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 39,160 | 0.08 | |
Q3  2018 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 8.13% | 72,450 | 0.63 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 61.55% | 62,680 | 0.13 | |
Q2  2018 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 21.28% | 240,931 | 1.77 | |
Q1  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 5.85% | 4,650 | 0.01 | |
≡ | David Rolfe - Wedgewood Partners | Reduce 15.48% | 207,421 | 1.33 | |
Q4  2017 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 0.24% | 3,285 | 0.01 | |
Q2  2017 | |||||
≡ | David Rolfe - Wedgewood Partners | Reduce 24.25% | 275,724 | 1.00 | |
Q1  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 19.64% | 7,550 | 0.01 | |
Q3  2016 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 16.72% | 5,400 | 0.01 | |
Q3  2015 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 3,920 | 0.00 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.